慈天元，女，药学院药剂系副教授，硕士生导师。
教育背景
2010.9-2015.6 复旦大学 高分子科学系 高分子化学与物理 博士
2006.9-2010.6 中国药科大学 药学院 理科基地班 学士
工作经历
2015.7-2018.7 中国药科大学药学院药剂系讲师
2018.7至今中国药科大学药学院药剂系副教授
研究方向及成果
研究方向主要围绕构建新型药物递释系统及开发新型药用高分子材料，具体研究内容包括（1）新型靶向纳米给药系统；（2）新型药用高分子材料的设计与合成；（3）可注射性长效缓控释制剂
主持的科研项目包括国家自然科学基金青年基金、江苏省自然科学基金青年基金及中央高校基本科研业务经费培育项目，此外亦参与国家自然科学基金面上项目及多项企业委托项目。
近年来，以第一作者或通讯作者发表SCI论文13篇，累积影响因子逾50分。代表性论文如下：
[1] Haifeng Sun, Dinglingge Cao, Yanhong Liu, Hui Wang, Xue Ke*, Tianyuan Ci*, Low molecular weight heparin based reduction sensitive nanoparticles for antitumor and anti-metastasis of orthotopic breast cancer.Biomaterials Science, 2018, 6, 2172-2188. (IF 5.831)
[2] Yi Chen, Haohuan Li, Yueyang Deng, Haifeng Sun, Xue Ke*, Tianyuan Ci*, Near-infrared light triggered drug delivery system for higher efficacy of combined chemo-photothermal treatment, Acta Biomaterialia, 2017, 51, 374-392. (IF 6.319)
[3] Danrong Hu, Omar Mezghrani, Lei Zhang, Yi Chen, Xue Ke*, Tianyuan Ci*, GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy, International Journal of Nanomedicine, 2016, 11, 5125-5147. (IF 4.320)
[4] Tianyuan Ci, Ting Li, Guangtao Chang, Lin Yu, Jiandong Ding*, Simply mixing with poly(ethylene glycol) enhances the fraction of the active chemical form of antitumor drugs of camptothecin family, Journal of Controlled Release, 2013, 169, 329–335. (IF 7.261)
[5] Tianyuan Ci, Chen Liang, Lin Yu, Jiandong Ding*, Tumor regression achieved by encapsulating a moderately soluble drug into a polymeric thermogel, Scientific Reports, 2014, 4, 5473. (IF 5.578)
[6] Tianyuan Ci, Ting Li, Liang Chen, Guangtao Chang, Lin Yu, Jiandong Ding*, Effects of “mature micelle” formation of Pluronic P123 on equilibrium between lactone and carboxylate forms of 10-hydrocamptothecin in water, Polymer Chemistry, 2013, 4, 3245-3255. (IF 5.368)

联系方式
Email：citianyuan_cpu@163.com
Tel：**